Inovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 6c/Share
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.09 --0%
Financial Fact:
License fee and milestone revenue from affiliated entity: 574.6K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
License fee and milestone revenue from affiliated entity: 574.6K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.1 million.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- HomeTrust to acquire Blue Ridge Bankshares in $448M all-stock deal
- DA Davidson Reiterates Buy Rating on Walmart (WMT) Ahead of Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
